Literature DB >> 3244721

Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds.

C Stein1, M J Millan, A Herz.   

Abstract

Unilateral intraplantar injection of Freund's complete adjuvant (FCA) into one hindpaw of rats led to a localized inflammation that became apparent within 12 hours and reached its peak between 2 and 3 weeks. FCA-treated rats displayed a diminished rate of body weight gain, a reduction of food and water intake and a disruption of circadian temperature regulation, as well as decreased locomotor activity and pronounced scratching behavior in the open field. Paw pressure thresholds were reduced only in inflamed paws. Contralateral, noninflamed paws showed comparable thresholds to those of control animals. Tail-flick and tail-pressure responses were not different from controls. These data suggest that FCA-treated animals experience increased noxious input from the inflamed limb and that changes in thresholds to acutely applied nociceptive stimuli are due to a peripheral hypersensitivity of inflamed tissue. The present condition resembles most closely a state of acute inflammatory pain. The term "chronic pain" in its strict sense is not appropriate in this model.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244721     DOI: 10.1016/0091-3057(88)90372-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  81 in total

1.  Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567.

Authors:  Scott D Kuduk; Christina N Di Marco; Vera Bodmer-Narkevitch; Sean P Cook; Matthew J Cato; Aneta Jovanovska; Mark O Urban; Michael Leitl; Nova Sain; Annie Liang; Robert H Spencer; Stefanie A Kane; George D Hartman; Mark T Bilodeau
Journal:  ACS Chem Neurosci       Date:  2009-10-06       Impact factor: 4.418

2.  Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms.

Authors:  Felipe F Rodrigues; Marcela I Morais; Ivo S F Melo; Paulo S A Augusto; Marcela M G B Dutra; Sarah O A M Costa; Fábio C Costa; Franciele A Goulart; Alysson V Braga; Márcio M Coelho; Renes R Machado
Journal:  Inflammopharmacology       Date:  2019-11-25       Impact factor: 4.473

3.  Sex differences in the anatomical and functional organization of the periaqueductal gray-rostral ventromedial medullary pathway in the rat: a potential circuit mediating the sexually dimorphic actions of morphine.

Authors:  Dayna R Loyd; Anne Z Murphy
Journal:  J Comp Neurol       Date:  2006-06-10       Impact factor: 3.215

4.  Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.

Authors:  P J Cabot; L Carter; C Gaiddon; Q Zhang; M Schäfer; J P Loeffler; C Stein
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Persistent pain model reveals sex difference in morphine potency.

Authors:  Xiaoya Wang; Richard J Traub; Anne Z Murphy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-02-23       Impact factor: 3.619

6.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

Review 7.  Intracellular signaling in primary sensory neurons and persistent pain.

Authors:  Jen-Kun Cheng; Ru-Rong Ji
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 3.996

8.  Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.

Authors:  C Stein; A H Hassan; R Przewłocki; C Gramsch; K Peter; A Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 9.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

10.  Suppression of voluntary wheel running in rats is dependent on the site of inflammation: evidence for voluntary running as a measure of hind paw-evoked pain.

Authors:  Peter M Grace; Keith A Strand; Steven F Maier; Linda R Watkins
Journal:  J Pain       Date:  2013-10-12       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.